312 related articles for article (PubMed ID: 9382581)
1. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
Elewski BE
Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581
[No Abstract] [Full Text] [Related]
2. Onychomycosis in children: a survey of 46 cases.
Romano C; Papini M; Ghilardi A; Gianni C
Mycoses; 2005 Nov; 48(6):430-7. PubMed ID: 16262881
[TBL] [Abstract][Full Text] [Related]
3. Non-dermatophytes in onychomycosis of the toenails.
Ellis DH; Watson AB; Marley JE; Williams TG
Br J Dermatol; 1997 Apr; 136(4):490-3. PubMed ID: 9155945
[TBL] [Abstract][Full Text] [Related]
4. Case report: onychomycosis due to Trichophyton schoenleinii.
Macura AB; Krzyściak P; Skóra M; Gniadek A
Mycoses; 2012 Mar; 55(2):e18-9. PubMed ID: 21771109
[No Abstract] [Full Text] [Related]
5. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
Gerasimchuk EV; Gerasimov VV; Molchanov BA
Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
[No Abstract] [Full Text] [Related]
6. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine vs. placebo for onychomycosis in black patients.
Billstein S; Kianifard F; Justice A
Int J Dermatol; 1999 May; 38(5):377-9. PubMed ID: 10369551
[No Abstract] [Full Text] [Related]
8. Nondermatophytic onychomycosis by Fusarium oxysporum in an immunocompetent host.
Shah SR; Dalal BD; Modak MS
J Mycol Med; 2016 Mar; 26(1):e18-21. PubMed ID: 26852190
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of onychomycosis].
Suhonen R; Karvonen J
Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
[No Abstract] [Full Text] [Related]
12. [Onychomycosis is rare in young children, and treatment is a task for dermatological specialists].
Haugaard LK; Skov L; Arendrup MC; Saunte DM
Ugeskr Laeger; 2013 Sep; 175(40):2343-4. PubMed ID: 24079324
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine and onychomycosis.
Eastcott DF
N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145
[No Abstract] [Full Text] [Related]
14. Other fungi causing onychomycosis.
Moreno G; Arenas R
Clin Dermatol; 2010 Mar; 28(2):160-3. PubMed ID: 20347658
[TBL] [Abstract][Full Text] [Related]
15. Nondermatophytes. Pathogen or distracter in onychomycosis.
Lagana FJ
Clin Podiatr Med Surg; 1995 Apr; 12(2):255-62. PubMed ID: 7600499
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis.
Maleszka R; Adamski Z; Dworacki G
Mycoses; 2001 Dec; 44(11-12):487-92. PubMed ID: 11820262
[TBL] [Abstract][Full Text] [Related]
17. Onychomycosis due to Onychocola canadensis.
O'Donoghue NB; Moore MK; Creamer D
Clin Exp Dermatol; 2003 May; 28(3):283-4. PubMed ID: 12780715
[TBL] [Abstract][Full Text] [Related]
18. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
19. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
[No Abstract] [Full Text] [Related]
20. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Warrick D; Church L
J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
